4-N-BOC-Aminopiperidine
[CAS# 73874-95-0]

Identification

• Classification: Pharmaceutical intermediate >> Heterocyclic compound intermediate >> Pyridine compound >> Pyridine derivative
• Name: 4-N-BOC-Aminopiperidine
• Synonyms: 4-N-(tert-Butoxycarbonyl)aminopiperidine
• Molecular Formula: C₁₀H₂₀N₂O₂
• Molecular Weight: 200.28
• CAS Registry Number: 73874-95-0
• EC Number: 616-026-6
• SMILES: CC(C)(C)OC(=O)NC1CCNCC1

Properties

• Density: 1.0±0.1 g/cm³ Calc.^*
• Melting point: 162 - 166 ºC (Expl.)
• Boiling point: 304.8±31.0 ºC 760 mmHg (Calc.)^*
• Flash point: 138.2±24.8 ºC (Calc.)^*
• Index of refraction: 1.48 (Calc.)^*

^* Calculated using Advanced Chemistry Development (ACD/Labs) Software.

Safety Data

• Hazard Symbols: GHS07 Warning
• Hazard Statements: H315-H319-H335
• Precautionary Statements: P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Hazard Classification

Hazard	Class	Category Code	Hazard Statement
Specific target organ toxicity - single exposure	STOT SE	3	H335
Skin irritation	Skin Irrit.	2	H315
Eye irritation	Eye Irrit.	2	H319
Skin corrosion	Skin Corr.	1B	H314
Serious eye damage	Eye Dam.	1	H318
Eye irritation	Eye Irrit.	2A	H319
Skin corrosion	Skin Corr.	1	H314

Discovory and Applicatios

4-(N-BOC-amino)piperidine is a protected amino piperidine derivative featuring a tert-butoxycarbonyl (BOC) group on the nitrogen atom of the piperidine ring, with an amine substituent at the 4-position. The molecular formula is C₁₀H₂₀N₂O₂, and the compound typically appears as a white crystalline solid. It is soluble in common organic solvents such as methanol, ethanol, dichloromethane, and ethyl acetate. The BOC protecting group enhances stability and allows selective deprotection under mild acidic conditions, making this compound a versatile building block in organic synthesis.

In organic chemistry, 4-(N-BOC-amino)piperidine is widely used in pharmaceutical intermediate synthesis, particularly in the design of aminopiperidine scaffolds. Removal of the BOC group under acidic treatment or hydrogenolytic conditions liberates the free amine, which can then undergo further functionalization. The 4-amino functionality enables conjugation to pharmacophores or the creation of heterocyclic structures via reductive amination and coupling chemistry. As a result, the molecule serves as a key entry point for constructing complex, biologically active compounds.

Synthetic routes to this compound commonly begin with piperidin-4-one derivatives. One method involves reacting N-benzyl-4-piperidone to introduce the BOC functionality, followed by methylenation to install functionality at the 4-position, and finally, catalytic hydrogenation to remove protecting groups and yield the desired BOC-protected amino compound in high yield. Alternative synthetic strategies employ direct BOC protection of 4-aminopiperidine or multistep transformations involving ketal intermediates to streamline the reaction sequence.

4-(N-BOC-amino)piperidine has found application in medicinal chemistry for elaborating libraries of aminopiperidine derivatives. These derivatives are investigated as candidates targeting muscarinic receptors, central nervous system pathways, viral entry receptors such as CCR5, and enzyme inhibition targets. For example, in DPP-4 inhibitor research, aminopiperidine analogues, which can be derived from BOC-protected precursors, are valuable for designing antidiabetic compounds with tailored receptor interactions.

Commercially, this compound is offered by chemical suppliers in high-purity grades (typically ≥96–98 %), often with a melting point of approximately 162–166 °C. It is stored under refrigerated or ambient conditions and handled using standard protective equipment to guard against irritation. The compound is not considered particularly volatile but should be managed carefully in laboratory settings.

In summary, 4-(N-BOC-amino)piperidine is a strategically protected aminopiperidine intermediate with broad utility in organic and medicinal chemistry. Its structural features—BOC-protected nitrogen and a reactive amino substituent—provide flexibility for downstream functionalization, making it a valuable tool in complex molecule synthesis.

References

2025. Discovery, optimization and biological evaluation of chromone derivatives as novel BRD4 inhibitors. Medicinal Chemistry Research, 34(3).
DOI: 10.1007/s00044-025-03380-x

2023. Discovery of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of pain. Medicinal Chemistry Research, 32(6).
DOI: 10.1007/s00044-023-03079-x

2022. Exploration of NMI-MsCl mediated amide bond formation for the synthesis of novel 3,5-substituted-1,2,4-oxadiazole derivatives: synthesis, evaluation of anti-inflammatory activity and molecular docking studies. Molecular Diversity, 27(5).
DOI: 10.1007/s11030-022-10536-z